AmoyDx

300685

Current ValuationThe current P/E ratio is 21.53, below the reasonable range, cheaper than 93.48% of the time in the past 5 years, and the industry ranks 6/84, the industry Median 19.89.

21.53xP/E
Stock price¥19.09Earnings per share¥0.89

Historical Valuation

P/E ratioTypical rangeMedian

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
Industry median 19.89x
023466992

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
Industry median 19.89x
0x40x80x120x160x200x
P/E ratio
Name/Symbol
688428SHInnoCare
31.56x10.53%¥43.00B
603087SHGan & Lee
34.48x23.32%¥40.80B
002252SZShanghai RAAS
28.74x16.67%¥31.18B
300896SZIMEIK
26.70x10.26%¥26.40B
600161SHBTBP
34.77x34.01%¥24.34B
002007SZHUALAN BIOLOGICAL
37.41x35.93%¥21.94B
688266SHZelgen
37.97x398.39%¥21.60B
688278SHAMOYTOP
21.28x19.44%¥17.93B
301301SZYili Chuanning Bio
32.93x20.59%¥16.14B
300685SZAmoyDx
21.53x1.11%¥7.45B
300406SZBSBE
29.14x121.88%¥7.30B
300841SZKanghua Biological
24.09x22.92%¥6.22B
002880SZWEIGUANG BIOLOGICAL
25.66x20.82%¥4.35B
300439SZMedicalsystem
36.24x--¥3.64B
300653SZZHBIO
39.10x20.65%¥2.49B

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.